Take-Two added to Wedbush's Best Ideas List on strong franchise moat, GTA VI potential
proactiveinvestors.com
Want to monitor CLNN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CLNNClene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.